New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 5, 2019 - Endo announced that one of its operating companies, Par, launched an authorized generic version of Merck’s Proventil HFA (albuterol) inhalation aerosol.
Download PDF
Return to publications
